12th Edition of Global Conference on
Pharmaceutics and Novel Drug Delivery Systems
Event Book
Event program
Scientific Program
About
The 12th Edition of Global Conference on Pharmaceutics and Novel Drug Delivery Systems, held from September 11–13, 2025, in Valencia, Spain, concluded successfully, marking another significant milestone in the field of pharmaceutical sciences. The conference brought together leading researchers, formulation scientists, industry experts, and regulatory professionals to explore the latest innovations in drug delivery technologies and pharmaceutics. With a strong focus on cutting-edge drug delivery systems, nanotechnology-based therapeutics, personalized medicine, and regulatory advancements, the event provided a dynamic platform for knowledge exchange and collaboration. Attendees benefited from insightful keynote presentations, technical sessions, poster displays, and interactive discussions that addressed both current challenges and future trends in drug formulation and delivery. The vibrant setting of Valencia, coupled with the enthusiastic participation of both on-site and virtual attendees, enriched the experience and fostered meaningful networking opportunities. The conference played a pivotal role in driving forward-thinking research and inspiring novel approaches to enhance the efficacy, safety, and accessibility of therapeutic solutions.
The success of this 12th edition underscores the growing importance of innovation in pharmaceutics and drug delivery systems in improving global healthcare outcomes.
Scientific Committee Members
Yong Xiao Wang
Albany Medical College, United States
Consolato M Sergi
Universities of Alberta and Ottawa, Canada
Vladlen Slepak
University of Miami Miller School of Medicine, United States
Andreas M Papas
Antares Health Products, United States
Sergey Suchkov
N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Luis Jesus Villarreal Gomez
FCITEC - Universidad Autónoma de Baja California, MexicoSpeakers
Axel H Schonthal
University of Southern California, United States
Bernd Blobel
University of Regensburg, Germany
Gurpreet Singh
IQVIA, United Kingdom
Rassa Pegahi
UPSA, France
Natassa Pippa
University of Athens, Greece
Krisztian Pamlenyi
University of Szeged, Hungary
Iria Naveira Souto
Reig Jofre | University of Barcelona, Spain
Punam Kumari
Pharmacovigilance Consultant, Clinexel, United KingdomGallery
Reviews
Title : Eliminating implant failure in humans with nanomaterials: 30,000 cases and counting
Thomas J Webster, Hebei University of Technology, United States
Title : Analytical strategies for solid-state forms in drug development
Maria Cristina Gamberini, University of Modena e Reggio Emilia, Italy
Title : Managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Ectopically expressed olfactory receptors as an untapped family of drug targets and discovery of agonists and antagonists of OR51E1, an understudied G protein-coupled receptor
Vladlen Slepak, University of Miami Miller School of Medicine, United States
Title : Search for novel biomarkers and therapeutic targets for inflammatory disease
Madhav Bhatia, University of Otago, New Zealand
Title : Innovative development and delivery of biologics for chronic obstructive pulmonary disease
Yong Xiao Wang, Albany Medical College, United States